Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation.
Título
Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation.
Autor
Pei-Gang Wang, Dong-Jiang Tang, Zhan Hua, Zai Wang, Jing An
Fecha
2020
Materia
membrane fusion, endocytosis
Identificador
10.1038/s41421-020-00217-2
Fuente
Cell discovery
Archivos
Colección
Citación
Pei-Gang Wang, Dong-Jiang Tang, Zhan Hua, Zai Wang, Jing An, “Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation.,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/6465.
Position: 20120 (13 views)